Notification of managers' transactions

ANNOUNCEMENT NO. 263

Notification of managers’ transactions

ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.

See the transactions of CEO Martin Helbo Behrens in the attached PDF document.

For further information, please contact:

Niels Høy Nielsen, CFOTelephone (+45) 2551 8724

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.

ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For further information, go to www.chemometec.com.

Attachment

  • 2024-05-13 Martin Helbo Behrens Notification
Chemometec AS (TG:CHY)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Chemometec AS 차트를 더 보려면 여기를 클릭.
Chemometec AS (TG:CHY)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Chemometec AS 차트를 더 보려면 여기를 클릭.